Body

Yeast protein breaks up amyloid fibrils and disease protein clumps differently

PHILADELPHIA — Several fatal brain disorders, including Parkinson's disease, are connected by the misfolding of specific proteins into disordered clumps and stable, insoluble fibrils called amyloid. Amyloid fibrils are hard to break up due to their stable, ordered structure. For example, α-synuclein forms amyloid fibrils that accumulate in Lewy Bodies in Parkinson's disease. By contrast, protein clumps that accumulate in response to environmental stress, such as heat shock, possess a less stable, disordered architecture.

Seattle Children's Research Institute helps identify causes of sagittal craniosynostosis

Seattle Children's Research Institute, together with an international team of scientists and clinicians from 22 other institutions, have identified two genetic risk factors for the most common form of non-syndromic craniosynostosis, a birth defect in which the bony plates of an infant's skull prematurely fuse. The condition is known as sagittal craniosynostosis and often results in an abnormal head shape and facial features.

The study identified two genes (BMP2 and BBS9) associated with sagittal craniosynostosis that are known to be involved in broader skeletal development.

1 week at a health spa improves your health, study shows

(PHILADELPHIA) – Take off those Thanksgiving pounds with a week at a spa retreat. A new study shows that not only are they relaxing and nourishing, but they are safe and a week-long spa stay can correspond with changes in our physical and emotional well-being.

TGen, Scottsdale Healthcare lead worldwide study of new drug for patients with pancreatic cancer

SCOTTSDALE, Ariz. — A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen).

Can't stop? Smoking less helps

Countless studies demonstrate the virtues of complete smoking cessation, including a lowered risk of disease, increased life expectancy, and an improved quality of life. But health professionals acknowledge that quitting altogether can be a long and difficult road, and only a small percentage succeed.

Embattled childhoods may be the real trauma for soldiers with PTSD

New research on posttraumatic stress disorder (PTSD) in soldiers challenges popular assumptions about the origins and trajectory of PTSD, providing evidence that traumatic experiences in childhood - not combat - may predict which soldiers develop the disorder.

Psychological scientist Dorthe Berntsen of Aarhus University in Denmark and a team of Danish and American researchers wanted to understand why some soldiers develop PTSD but others don't. They also wanted to develop a clearer understanding of how the symptoms of the disorder progress.

Limiting neurosurgery residents' work hours hasn't decreased complication rates

Philadelphia, Pa. (November 19, 2012) – Limits on duty hours for residents in training haven't increased the safety of one common brain operation, concludes a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

A code of silence in acute myeloid leukemia

The development of acute myeloid leukemia (AML) is associated with a variety of genetic changes. Some of these alterations are epigenetic, wherein the sequence of the genes is unchanged, but chemical modifications to the DNA alters gene expression.

In a study published in the Journal of Clinical Investigation, researchers led by Daniel Tenen at Beth Israel Deaconess Medical Center found that a transcriptional regulator known as C/EBPG was highly expressed in a subset of AML samples that had an epigenetically silenced C/EBPA gene.

A code of silence in acute myeloid leukemia

The development of acute myeloid leukemia (AML) is associated with a variety of genetic changes. Some of these alterations are epigenetic, wherein the sequence of the genes is unchanged, but chemical modifications to the DNA alter gene expression. In a study published in the Journal of Clinical Investigation, researchers led by Daniel Tenen at Beth Israel Deaconess Medical Center found that a transcriptional regulator known as C/EBPG was highly expressed in a subset of AML samples that had an epigenetically silenced C/EBPA gene.

New species literally spend decades on the shelf

Many of the world's most unfamiliar species are just sitting around on museum shelves collecting dust. That's according to a report in the November 20th issue of the Cell Press journal Current Biology showing that it takes more than 20 years on average before a species, newly collected, will be described.

No elevated 10-year risk of heart disease for people who become ill during a large E. coli outbreak

According to a new study in CMAJ (Canadian Medical Association Journal), people who became ill during the Walkerton, Ontario, Escherichia coli O157:H7outbreak were not at greater risk of heart disease or stroke 10 years later.

Toward competitive generic drug prices in Canada

The commitment of Canadian premiers to lower generic drug prices is a major change in how the country prices generic drugs, and government should learn from past attempts, states an article published in CMAJ (Canadian Medical Association Journal).

Generic drug prices are higher in Canada than in other industrialized countries. The authors argue that the premiers' call for a national bulk purchasing program, made earlier in 2012, is a positive step for Canadians.

The Journal of Biological Chemistry commemorates an important 1987 discovery

It has been 25 years since the identification of two proteins that facilitate communication between nerve cells – a significant achievement that revealed a group of related proteins. In recognition of this advancement, the Journal of Biological Chemistry has published a series of articles that assess what we know about each family member in this group and where that research is headed.

Protein test is first to predict rate of progression in Lou Gehrig’s disease

JACKSONVILLE, Fla. — A novel test that measures proteins from nerve damage that are deposited in blood and spinal fluid reveals the rate of progression of amyotrophic lateral sclerosis (ALS) in patients, according to researchers from Mayo Clinic's campus in Florida, Emory University and the University of Florida.

Singular polymer, multiple functions

Akron, Ohio, Nov. 19, 2012 —Working in the lab for the last few years, three generations of University of Akron polymer scientists say their mutual and passionate curiosity about science has led to their discovery of a first-of-its-kind, easily adaptable biocompatible polymer structure able to fight infection, filter water and perform a host of other functions.